![](https://www.jafroninternational.com/xby/uploadfile/202201/100bc1ba203004d.jpg)
![](https://www.jafroninternational.com/xby/uploadfile/202201/029ad79ac060f14.jpg)
-
HA230 Applied in a Patient Suffering from Severe D...2023-01-11
-
Jafron Q3 Report 2022: Prepping for the Winter2023-01-11
-
Jafron:Master the acute phase2023-01-11
-
The first Vietnam clinical case competition was su...2023-01-11
-
Jafron HA130 in Medical Research: Another Breakthr...2023-01-11
-
The way forward of Jafron in Europe2022-07-27
-
A Clinical Case about Septic Shock from Vietnam2022-07-08
-
Jafron Biomedical at the 40th Vicenza Course on AK...2022-06-22
-
Jafron Presents at the 59th ERA Congress2022-05-27
-
HA230 Applied in a Patient Suffering from Severe Deltamethrin Poisoning2023-01-11
-
Jafron Q3 Report 2022: Prepping for the Winter2023-01-11
-
Jafron:Master the acute phase2023-01-11
-
The first Vietnam clinical case competition was successfully held2023-01-11
-
Jafron HA130 in Medical Research: Another Breakthrough2023-01-11
-
The way forward of Jafron in Europe2022-07-27
-
A Clinical Case about Septic Shock from Vietnam2022-07-08
-
Jafron Biomedical at the 40th Vicenza Course on AKI&CRRT2022-06-22
-
Jafron Presents at the 59th ERA Congress2022-05-27